SEC Company Response from Advaxis, Inc. (ADXS) (CIK 0001100397) — Oct 14, 2021
Advaxis, Inc. (ADXS) (CIK 0001100397)
Date: Oct. 14, 2021 · CIK: 0001100397 · Accession: 0001493152-21-025371
AI Filing Summary & Sentiment
File numbers found in text: 333-259065
Show Raw Text
CORRESP
1
filename1.htm
Advaxis,
Inc.
9
Deer Park Drive, Suite K-1
Monmouth
Junction, NJ 08852
October 14,
2021
U.S.
Securities and Exchange Commission
Division
of Corporate Finance
Office
of Life Sciences
100
F Street NE
Washington,
DC 20549
Attention:
David Gessert
VIA
EDGAR
Re:
Advaxis, Inc.
Registration
Statement on Form S-4
Filed
August 25, 2021
File
No. 333-259065
Dear
Mr. Gessert:
In
accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby
request acceleration of the effective date of Amendment No. 1 to the Registration Statement on Form S-4 (File No. 333-259065) (the
“Registration Statement”) of Advaxis, Inc. We respectfully request that the Registration Statement become effective
as of 4:00 p.m., Eastern time, on October 15, 2021, or as soon as practicable thereafter. Once the Registration Statement has been declared
effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Justin W. Chairman at
(215) 963-5061 or Emily Drazan Chapman at (202) 739-5699.
Very Truly Yours,
Advaxis, Inc.
By:
/s/
Kenneth A. Berlin
Name:
Kenneth
A. Berlin
Title:
President
and Chief Executive Officer
cc:
Morgan,
Lewis & Bockius LLP